October 19, 2017 (HealthDay News) Yescarta (axicabtagene ciloleucel) has been approved by the U.S. Food and Drug Administration for individuals with certain types of large B-cell lymphoma who have not …
Gene Tx Approved for Certain Types of B-Cell Lymphoma Read More
October 12, 2017 (HealthDay News) Patients with severe neurotoxicity after infusion of CD19-targeted chimeric antigen receptor-modified T (CAR-T) cells have evidence of endothelial activation, according to a study published online …
Neurotoxicity Characterized After Infusion of CD19 CAR-T Cells Read More
December 11, 2017 (HealthDay News) Second study shows benefit in relapsed or refractory B-cell lymphoma, follicular lymphoma Axicabtagene ciloleucel (axi-cel), an autologous anti-CD19 chimeric antigen receptor (CAR) T-cell therapy and …
ASH: Anti-CD19 CAR T-Cell Tx Beneficial in B-Cell Lymphomas Read More
September 8, 2016 (HealthDay News) Researchers identify treatment characteristics that correlate with therapeutic response, toxicity Immunotherapy with CD19 chimeric antigen receptor (CAR)-modified T cells in a defined CD4+/CD8+ ratio can …
Remission Up With T Cell Therapy for Non-Hodgkin’s Lymphoma Read More
December 29, 2016 (HealthDay News) Tumors regressed after intracranial infusions of T cells engineered to target tumor-associated antigen Treatment with autologous chimeric antigen receptor (CAR)-engineered T cells targeting the tumor-associated …
Case Report: Adoptive T-Cell Tx Shows Promise in Glioblastoma Read More
February 16, 2016 (HealthDay News) Patient’s T cells are engineered with chimeric antigen receptors A new T-cell immunotherapy has led to sustained regression in many previously relapsing and treatment-resistant cases …
New Immune Tx Achieves Remission in B-Cell Malignancies Read More
June 6, 2017 (HealthDay News) Findings from trial of chimeric antigen receptor T cells targeting B-cell maturation protein A new type of immunotherapy appears to provide long-lasting protection against multiple …
ASCO: CAR T-Cell Therapy Promising in Multiple Myeloma Read More